Table 2 Treatment outcomes of patients who underwent chemotherapy-assisted endoresection
No. | Follow-up (months) | Recurrence | Metastasis | Complicated cataract | Retreatment | Pre-op BCVA | Last BCVA |
|---|---|---|---|---|---|---|---|
01 | 83 | No | No | No | No | HM | FC |
02 | 81 | No | No | No | No | HM | 20/400 |
03 | 79 | No | No | No | No | LP | 20/200 |
04 | 65 | No | No | No | No | LP | 20/800 |
05 | 33 | No | No | No | No | LP | 20/100 |
06 | 30 | No | No | No | Cataract surgery | LP | 20/125 |
07 | 23 | No | No | Yes | No | HM | 20/400 |
08 | 23 | Yes | No | Yes | PPV, IViC, cataract surgery | LP | 20/200 |
09 | 23 | Yes | No | Yes | Laser, IViC, PPV, Cataract surgery | HM | FC |
10 | 18 | No | No | Yes | Cataract surgery | LP | HM |
11 | 12 | No | No | No | No | LP | LP |